Overview
The study is a single-center, prospective, non-randomized controlled study. The primary objective is to examine the clinical outcomes of utilizing Deep Inspiration Breath Hold (DIBH) in conjunction with hypo-fractionated radiotherapy for patients diagnosed with left-sided breast cancer with a particular focus on its potential to reduce the incidence of cardiac-related clinical and subclinical events.Participants will revieve large segmentation sadiotherapy ± DIBH for left breast cancer and be followed up to gather their clinical cardiac imformation.
Eligibility
Inclusion Criteria:
- 18-70 years old, female, life expectancy > 5 years
- ECOG 0, 1, 2 points
- Pathologically diagnosed with left breast cancer and underwent breast-conserving surgery or modified radical mastectomy
- The patient will receive radiation therapy to the entire breast or chest wall ± the lymphatic drainage area above and below the clavicle ± the lymphatic drainage area in the axilla.
- No prior neoadjuvant chemotherapy or breast reconstruction.
- No active cardiac disease, myocardial infarction, or congestive cardiac failure at baseline.
- Patients can hold their breath for at least 30 seconds after training
- Patients who can be followed up and agree to follow the plan.
- Sign the consent form.
Exclusion Criteria:
- Lesions were observed on both sides of the breast.
- Diagnosis could not be confirmed by pathology.
- Distant metastasis was identified.
- The patient had undergone neoadjuvant chemotherapy or breast reconstruction surgery.
- Severe cardiac insufficiency; myocardial infarction or uncorrected unstable cardiac arrhythmia or uncorrected unstable angina within the last 3 months; or pericardial disorders
- The patient's New York Heart Association (NYHA) cardiac classification is within categories 2-4.
- A history of chronic lung disease, including conditions that may contribute to ductal dilatation, such as chronic obstructive pulmonary disease (COPD) and interstitial pneumonia.
- Previous mediastinal radiotherapy.
- Previous or concurrent second primary malignant tumor (except skin cancer that is not a malignant black pigmented tumor, papillary/follicular carcinoma of the thyroid, carcinoma in situ of the cervix, and contralateral non-invasive breast cancer).
- Irradiation of the lymphatic drainage area of the internal breast is required.